Author:
Mbuagbaw Lawrence,Guglielmetti Lorenzo,Hewison Catherine,Bakare Nyasha,Bastard Mathieu,Caumes Eric,Fréchet-Jachym Mathilde,Robert Jérôme,Veziris Nicolas,Khachatryan Naira,Kotrikadze Tinatin,Hayrapetyan Armen,Avaliani Zaza,Schünemann Holger J.,Lienhardt Christian
Publisher
Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference32 articles.
1. World Health Organization. Global tuberculosis report 2018. 2018 [cited 2018 Dec 11]. https://www.who.int/tb/publications/global_report
2. World Health Organization. Drug-resistant TB: totally drug-resistant TB FAQ. 2018 [cited 2018 12 Feb]. http://www.who.int/tb/areas-of-work/drug-resistant-tb/totally-drug-resistant-tb-faq
3. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.;Bonnet;Int J Tuberc Lung Dis,2016
4. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.;Borisov;Eur Respir J,2017
5. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.;Falzon;Eur Respir J,2017
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献